The British American Tobacco share price looks like a bargain. Am I buying?

A recent drop in the British American Tobacco share price makes the company look cheaper than it’s been for years. Does that make it a buy for me?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The British American Tobacco (LSE: BATS) share price took a 9% tumble in the last two weeks. It’s now down 18% for the year, whereas the FTSE 100 is up overall.

Might this be a rare buying opportunity? After all, no company on the Footsie has returned more to its shareholders since the index’s inception in 1984. 

Better still, a terrific forward dividend of over 8% and a price-to-earnings ratio lower than it has been in years makes the share price looks like a bargain. 

The big question is, am I going to buy in?

Number one for sales

First off, I’m encouraged by recent sales figures. BAT sells its cigarettes of brands like Dunhill, Lucky Strike and Camel worldwide, which helped it surpass £27bn in total revenue for 2022. 

Impressively, that makes the London-based firm the largest cigarette seller in the world based on sales volume. 

What’s more, revenue has been steadily increasing in recent years, driven by rising wealth in what the World Bank calls ‘middle-income countries’. There are actually more smokers now worldwide than ever before

20182019202020212022
Revenue£24.5bn£25.9bn£25.8bn£25.7bn£27.7bn
Margin25%22%25%26%24%
Net income£6.0bn£5.7bn£6.4bn£6.8bn£6.7bn
Free cash flow£9.4bn£8.2bn£9.0bn£9.0bn£9.7bn

Excellent and consistent margins of over 20% have led to over £6bn net income and £9bn free cash flow year after year. 

The business is simply drowning in cash, which means it has tons of money to pay out to its shareholders as dividends. 

Over 8% dividend yield

Today’s dividend yield stands at 7.97% which is the 4th highest on the entire FTSE 100. The forward dividend is even higher at 8.24% which would suit me very nicely.

Looking further back, dividends have been in the 5%-10% range since 2018. And the actual payout, which BAT makes quarterly, has been slowly increasing for years. 

Further good news is that the company spends around 75% of its income on dividends – a dividend cover of 1.3. That figure seems sustainable for payments long into the future.

A surprisingly cheap valuation

At today’s share price of £27.28, BAT doesn’t even seem like an expensive stock to buy. That’s despite the superb financials.

Its price-to-earnings ratio has dipped below 10 recently. That looks cheap compared to the FTSE 100 average of around 14.

A 0.93 price-to-book ratio looks like great value too. It’s a nice margin of safety when I’m – in theory, at least – getting £1 in assets for every 93p of investment.

Risks

A big danger when looking at stocks is to ignore any risks. And when I’m deciding whether to buy here, it’s hard to ignore that cigarette usage is shrinking in many countries.

Do I want to pick up some shares when, in the UK for example, 40% of adults smoked in 1980 but that went down to 13% in 2021?

BAT does make 14% of its revenue from non-combustibles – e-cigarettes, vapes and the like. But it’s unclear whether those products can fully replace cigarettes.

Am I buying?

All in all, the cheap price and repeated success of BAT over recent decades makes this a buy for me. This is why I took the opportunity to open a position recently.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

John Fieldsend has positions in British American Tobacco P.l.c. The Motley Fool UK has recommended British American Tobacco P.l.c. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »